S&P 500
(0.19%) 5 258.25 points
Dow J
(0.18%) 39 833 points
Nasdaq
(-0.04%) 16 392 points
Oil
(2.03%) $83.00
Gas
(1.69%) $1.747
Gold
(1.26%) $2 240.60
Silver
(0.99%) $25.00
Platinum
(1.36%) $922.05
USD/EUR
(0.39%) $0.927
USD/NOK
(0.82%) $10.86
USD/GBP
(0.13%) $0.792
USD/RUB
(0.14%) $92.57

Realtime updates for AnGes, Inc. [4563.T]

Exchange: JPX Sector: Healthcare Industry: Biotechnology
Last Updated28 Mar 2024 @ 02:15

-1.52% ¥ 65.00

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 02:15):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

AnGes, Inc., a biopharmaceutical company, engages in the research and development of gene-based medical products. Its lead product is Hepatocyte Growth Factor (HGF) Plasmid, a gene therapy for the treatment of critical limb ischemia, a serious impairment of blood circulation in the leg...

Stats
Today's Volume 1.26M
Average Volume 1.10M
Market Cap 13.08B
EPS ¥0 ( 2024-02-08 )
Next earnings date ( ¥0 ) 2024-05-07
Last Dividend ¥0 ( N/A )
Next Dividend ¥0 ( N/A )
P/E -1.650
ATR14 ¥0.324 (0.49%)

Volume Correlation

Long: -0.14 (neutral)
Short: 0.47 (neutral)
Signal:(56.942) Neutral

AnGes, Inc. Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

AnGes, Inc. Correlation - Currency/Commodity

The country flag 0.25
( neutral )
The country flag 0.37
( neutral )
The country flag 0.33
( neutral )
The country flag 0.22
( neutral )
The country flag 0.14
( neutral )
The country flag -0.35
( neutral )

AnGes, Inc. Financials

Annual 2023
Revenue: ¥152.99M
Gross Profit: ¥-3.06B (-2 001.33 %)
EPS: ¥-37.17
Q4 2023
Revenue: ¥50.33M
Gross Profit: ¥-802.81M (-1 595.22 %)
EPS: ¥-11.48
Q3 2023
Revenue: ¥51.43M
Gross Profit: ¥19.31M (37.55 %)
EPS: ¥0.170
Q2 2023
Revenue: ¥34.62M
Gross Profit: ¥1.44M (4.17 %)
EPS: ¥-10.25

Financial Reports:

No articles found.

AnGes, Inc.

AnGes, Inc., a biopharmaceutical company, engages in the research and development of gene-based medical products. Its lead product is Hepatocyte Growth Factor (HGF) Plasmid, a gene therapy for the treatment of critical limb ischemia, a serious impairment of blood circulation in the leg. The company is also developing NF-kB Decoy Oligonucleotide, a nucleic acid medicine that suppresses inflammation for diseases, including low back pain; drugs for treating atopic dermatitis and disc degeneration; medical devices for the prevention of vascular restenosis; cervical intraepithelial neoplasia therapeutic vaccines for cervical cancer; and DNA vaccines for high blood pressure through collaborative research agreement with Osaka University. AnGes, Inc. has alliances with BioMarin Pharmaceutical Inc. to market Naglazyme, a drug for the treatment of mucopolysaccharidosis VI in Japan; and Mitsubishi Tanabe Pharma Corporation for marketing HGF Plasmid for the treatment of peripheral arterial disease in the United States and Japan. It also has alliances with SHIONOGI & CO., LTD. for the marketing of drugs for external use containing NF-kB decoy oligonucleotide for skin diseases; Vical, Inc. for the development and marketing of Allovectin for cancer treatment; and Osaka University to develop a coronavirus vaccine. In addition, the company has a collaboration agreement with Brickell Biotech, Inc. to develop investigational plasmid DNA vaccine intended to prevent coronavirus in the United States, South America, and other markets. The company was formerly known as AnGes MG, Inc. and changed its name to AnGes, Inc. in July 2017. AnGes, Inc. was founded in 1999 and is headquartered in Ibaraki, Japan.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators